2° BACK FROM ASCO AND WORLD GI

1. 1.1) Burotto M, Zvirbule Z, Mochalova A, Runglodvatana Y, Herraez-Baranda L, Liu SN, Chan P, Shearer-Kang E, Liu X, Tosti N, Zanghi JA, Leutgeb B, Felip E.. IMscin001 Part 2: a randomised phase III, open-label, multicentre study examining the pharmacokinetics, efficacy, immunogenicity, and safety of atezolizumab subcutaneous versus intravenous administration in previously treated locally advanced or metastatic non-small-cell lung cancer and pharmacokinetics comparison with other approved indications. Ann Oncol. 2023 Aug;34(8):693-702. doi: 10.1016/j.annonc.2023.05.009. Epub 2023 Jun 1. Erratum in: Ann Oncol. 2024 May;35(5):482. doi: 10.1016/j.annonc.2023.12.005. PMID: 37268157.. 2024
   Articolo scientificoAnn Oncol. 2023 Aug;34(8):693-702. doi: 10.1016/j.annonc.2023.05.009. Epub 2023 Jun 1. Erratum in: Ann Oncol. 2024 May;35(5):482. doi: 10.1016/j.annonc.2023.12.005. PMID: 37268157.Leggi il PDF gratuito
2. 2.2) Turner NC, Im SA, Saura C, Juric D, Loibl S, Kalinsky K, Schmid P, Loi S, Sunpaweravong P, Musolino A, Li H, Zhang Q, Nowecki Z, Leung R, Thanopoulou E, Shankar N, Lei G, Stout TJ, Hutchinson KE, Schutzman JL, Song C, Jhaveri KL.. Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer.. N Engl J Med. 2024 Oct 31;391(17):1584-1596. doi: 10.1056/NEJMoa2404625. PMID: 39476340.. 2024
   Articolo scientificoN Engl J Med. 2024 Oct 31;391(17):1584-1596. doi: 10.1056/NEJMoa2404625. PMID: 39476340.Leggi il paperCerca versione gratuita
3. 3.3) Penault-Llorca F, Socinski MA. Emerging molecular testing paradigms in non-small cell lung cancer management-current perspectives and recommendations. Oncologist. 2025 Mar 24:oyae357. doi: 10.1093/oncolo/oyae357. Online ahead of print.. Emerging molecular testing paradigms in non-small cell lung cancer management-current perspectives and recommendations.. Oncologist. 2025 Mar 24:oyae357. doi: 10.1093/oncolo/oyae357. Online ahead of print.. 2025
   Articolo scientificoOncologist. 2025 Mar 24:oyae357. doi: 10.1093/oncolo/oyae357. Online ahead of print.Leggi il PDF gratuito
4. 4.4) Leighl NB, Ismaila N, Durm G, Florez N, Freeman-Daily J, Pellini B, Mishra DR, Schenk EL, Sequist L, Singh N, Bazhenova L.. Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline. Version 2024.3. J Clin Oncol. 2025 Feb 27:JCO2402786. doi: 10.1200/JCO-24-02786. Online ahead of print.. 2025
   Articolo scientificoVersion 2024.3. J Clin Oncol. 2025 Feb 27:JCO2402786. doi: 10.1200/JCO-24-02786. Online ahead of print.Leggi il paperCerca versione gratuita

I link ai libri possono contenere un codice affiliato Amazon: in qualità di affiliato, ECM Finder potrebbe ricevere una commissione sugli acquisti idonei, senza alcun costo aggiuntivo per te. I link ai paper rimandano alla fonte scientifica (DOI, versione open-access o ricerca accademica).